SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-140595
Filing Date
2020-12-30
Accepted
2020-12-30 17:01:49
Documents
1
Period of Report
2020-12-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2039599d2_4.html 4  
1 OWNERSHIP DOCUMENT tm2039599d2_4.xml 4 12862
  Complete submission text file 0001104659-20-140595.txt   14472
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Issuer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 213 SMITHFIELD ST PITTSBURGH PA 15222
Business Address
Stephan Dietrich A (Reporting) CIK: 0001774588 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 201426509